Source link : https://www.newshealth.biz/health-news/merck-says-keytruda-injection-on-par-with-approved-iv-version-in-trial/
(Reuters) -Merck said on Tuesday a study showed its injectable version of cancer drug Keytruda was not inferior to the currently approved intravenous formulation of its treatment, likely making it even more accessible and easier to administer. Shares of Merck were up 1.8% in premarket trading following the news. The pharmaceutical company was testing the […]
Author : News Health
Publish date : 2024-11-19 11:49:14
Copyright for syndicated content belongs to the linked Source.
inHealth